Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2589 | 2127 | 39.1 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
860 | 10928 | 5 LIPOXYGENASE//EXPT THER EUT REPERFUS INJURY//LEUKOTRIENES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | 5 LIPOXYGENASE | Author keyword | 133 | 37% | 13% | 283 |
2 | LEUKOTRIENE A4 HYDROLASE | Author keyword | 61 | 76% | 2% | 42 |
3 | 5 LIPOXYGENASE ACTIVATING PROTEIN | Author keyword | 59 | 71% | 2% | 48 |
4 | BLT2 | Author keyword | 53 | 89% | 1% | 24 |
5 | LEUKOTRIENE | Author keyword | 39 | 22% | 7% | 157 |
6 | LEUKOTRIENES | Author keyword | 24 | 14% | 7% | 155 |
7 | 5 LIPOXYGENASE ACTIVATING PROTEIN FLAP | Author keyword | 23 | 100% | 0% | 10 |
8 | CHEM 2 | Address | 21 | 36% | 2% | 48 |
9 | LEUKOTRIENE A4 | Author keyword | 21 | 75% | 1% | 15 |
10 | ALOX5AP | Author keyword | 20 | 66% | 1% | 19 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 5 LIPOXYGENASE | 133 | 37% | 13% | 283 | Search 5+LIPOXYGENASE | Search 5+LIPOXYGENASE |
2 | LEUKOTRIENE A4 HYDROLASE | 61 | 76% | 2% | 42 | Search LEUKOTRIENE+A4+HYDROLASE | Search LEUKOTRIENE+A4+HYDROLASE |
3 | 5 LIPOXYGENASE ACTIVATING PROTEIN | 59 | 71% | 2% | 48 | Search 5+LIPOXYGENASE+ACTIVATING+PROTEIN | Search 5+LIPOXYGENASE+ACTIVATING+PROTEIN |
4 | BLT2 | 53 | 89% | 1% | 24 | Search BLT2 | Search BLT2 |
5 | LEUKOTRIENE | 39 | 22% | 7% | 157 | Search LEUKOTRIENE | Search LEUKOTRIENE |
6 | LEUKOTRIENES | 24 | 14% | 7% | 155 | Search LEUKOTRIENES | Search LEUKOTRIENES |
7 | 5 LIPOXYGENASE ACTIVATING PROTEIN FLAP | 23 | 100% | 0% | 10 | Search 5+LIPOXYGENASE+ACTIVATING+PROTEIN+FLAP | Search 5+LIPOXYGENASE+ACTIVATING+PROTEIN+FLAP |
8 | LEUKOTRIENE A4 | 21 | 75% | 1% | 15 | Search LEUKOTRIENE+A4 | Search LEUKOTRIENE+A4 |
9 | ALOX5AP | 20 | 66% | 1% | 19 | Search ALOX5AP | Search ALOX5AP |
10 | LEUKOTRIENE B 4 | 19 | 19% | 4% | 88 | Search LEUKOTRIENE+B+4 | Search LEUKOTRIENE+B+4 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEUKOTRIENE SYNTHESIS | 74 | 48% | 5% | 113 |
2 | A4 HYDROLASE | 73 | 88% | 2% | 35 |
3 | 5 LIPOXYGENASE ACTIVATING PROTEIN | 65 | 45% | 5% | 108 |
4 | LTA4 HYDROLASE | 59 | 90% | 1% | 26 |
5 | ARACHIDONATE 5 LIPOXYGENASE | 45 | 54% | 3% | 58 |
6 | B 4 | 45 | 54% | 3% | 57 |
7 | B 4 RECEPTOR | 38 | 60% | 2% | 42 |
8 | 5 LIPOXYGENASE | 35 | 15% | 10% | 215 |
9 | LEUKOTRIENE BIOSYNTHESIS INHIBITOR | 30 | 62% | 1% | 31 |
10 | LEUKOTRIENE B 4 RECEPTOR | 29 | 43% | 2% | 50 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease | 2015 | 4 | 104 | 71% |
Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease | 2011 | 126 | 441 | 51% |
Mechanisms of disease: Leukotrienes | 2007 | 411 | 116 | 37% |
What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases | 2008 | 92 | 53 | 79% |
Targeting leukotriene B-4 in inflammation | 2014 | 7 | 118 | 75% |
Recent Advances in the Search for Novel 5-Lipoxygenase Inhibitors | 2014 | 9 | 43 | 56% |
5-Lipoxygenase: regulation of expression and enzyme activity | 2007 | 138 | 91 | 75% |
The role of leukotrienes in allergic diseases | 2015 | 2 | 194 | 31% |
Prostaglandins and leukotrienes: Advances in eicosanoid biology | 2001 | 1694 | 55 | 18% |
5-Lipoxygenase inhibitors: a review of recent developments and patents | 2010 | 47 | 106 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEM 2 | 21 | 36% | 2.3% | 48 |
2 | PHYSIOL CHEM 2 | 11 | 19% | 2.4% | 50 |
3 | PHARMACEUT ANALYT | 6 | 27% | 0.9% | 19 |
4 | PHARMACEUT CHEM ZAFES | 6 | 43% | 0.5% | 10 |
5 | CHAIR PHARMACEUT MED CHEM | 5 | 30% | 0.7% | 14 |
6 | CARDIOPULM PHARMACOL | 3 | 28% | 0.4% | 9 |
7 | ZAFES CMP | 2 | 38% | 0.2% | 5 |
8 | ARRHENIUS S A4 | 2 | 67% | 0.1% | 2 |
9 | CARDIOVASC P PHARMACEUT DEV | 2 | 67% | 0.1% | 2 |
10 | LUMINAL GASTROENTEROL | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000204264 | 5 OXO ETE//CLAUDE PEPPER//5 HETE |
2 | 0.0000180748 | PRANLUKAST//MONTELUKAST//CYSTEINYL LEUKOTRIENES |
3 | 0.0000156183 | 12 LIPOXYGENASE//15 LIPOXYGENASE//15 LIPOXYGENASE 1 |
4 | 0.0000109452 | TMEM132A//C FOS SERUM RESPONSE ELEMENT//FAS FASL INTERACTIONS |
5 | 0.0000104808 | EXPT THER EUT REPERFUS INJURY//RESOLVINS//LIPOXINS |
6 | 0.0000086752 | TENIDAP//TEPOXALIN//TENIDAP SODIUM |
7 | 0.0000086009 | GROWTH FACTOR DEPRIVATION THERAPY//A63162//MED DISCOVERY |
8 | 0.0000080627 | MEMORY AND LEARNING IMPAIRMENT//ALZHEIMER KOR KUTATOCSOPORT//FLAP PROTEIN |
9 | 0.0000080495 | MPGES 1//PROSTAGLANDIN E SYNTHASE//MPGES 2 |
10 | 0.0000075897 | LIPOPHILIC MOIETY//3 HEXENOL//BIOCARTOL |